ArticleJournal of neuro-oncology2018
A predictive value of von Willebrand factor for early response to Bevacizumab therapy in recurrent glioma.
Andrea Pace et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it